Langerhans cell histiocytosis is a rare disorder where certain immune system cells build up in the body, forming lesions that can affect nearly any organ or tissue. Though it primarily strikes young children, it can occur at any age, presenting challenges that range from mild and self-resolving to severe and life-threatening.
Understanding the Condition
Langerhans cell histiocytosis, commonly abbreviated as LCH, involves an abnormal accumulation of specialized immune cells called Langerhans cells. These cells, which are a type of white blood cell, normally help the body fight infections by patrolling the skin and other tissues. In healthy individuals, Langerhans cells are found throughout the body, particularly in the skin, lungs, lymph nodes, bone marrow, spleen, and liver.[1]
When someone develops LCH, their body produces too many immature Langerhans cells. These excess cells don’t function normally. Instead, they cluster together and accumulate in various parts of the body, where they can damage healthy tissue and form masses known as granulomas or lesions. The disease can affect just one location in the body, such as a single bone, or it can spread to multiple organs simultaneously.[2]
The nature of LCH has been debated for years. Many researchers now consider it a form of cancer, specifically a blood-related disorder, though this classification remains somewhat controversial. The discovery in 2010 of specific genetic mutations, particularly the BRAF V600E mutation, in LCH cells provided strong evidence that the condition shares characteristics with cancer. However, LCH behaves quite differently from typical cancers, as some cases resolve completely without treatment while others require intensive therapy.[6]
Epidemiology: How Common Is This Disease
Langerhans cell histiocytosis is genuinely rare in the general population. It occurs in approximately one to two out of every one million newborns each year. Among children aged 15 and younger, the disease affects about five out of every one million children annually. These numbers highlight just how uncommon this condition truly is, which partially explains why many physicians may not immediately recognize its symptoms.[1]
The disease shows a clear preference for younger age groups. Most people diagnosed with LCH are children, with the highest concentration of cases appearing in children between one and three years of age. The majority of diagnoses occur before age 10. While LCH is most often identified in early childhood, usually between ages two and three, it can technically develop at any point in life, including adulthood, though adult cases remain quite rare.[2]
There are some demographic patterns worth noting. The condition appears to be more common in boys than in girls. Among adults who develop LCH, particularly those with lung involvement, there is a strong association with smoking. About two-thirds of adult-onset cases affect only the lungs, and these patients are typically current or former smokers.[4]
The exact number of adults affected by LCH is not well established, though estimates suggest it occurs in up to 0.07 per million cases per year in adults, compared to 8.9 per million in children. The average age at diagnosis for adults is around 40 years. Hispanic ethnicity has been identified as a potential risk factor for developing the disease.[3][8]
Causes and Origins of the Disease
The precise cause of Langerhans cell histiocytosis remains unclear, though significant progress has been made in understanding its biological basis. Research has revealed that LCH is not an inherited condition passed from parents to children, nor is it contagious or spread from person to person. Rather, it appears to arise from genetic changes that occur during a person’s lifetime.[6]
Scientists have discovered that most cases of LCH involve mutations in genes that control cell growth and division. The most common of these is a mutation in the BRAF gene, particularly the BRAF V600E variant, which is found in many LCH patients. Other genes that may be affected include MAP2K1, RAS, and ARAF. These genes are all part of what scientists call the MAP kinase signaling pathway, a series of chemical signals that tell cells when to grow, divide, and perform their normal functions.[4][5]
When these genes develop mutations, they send incorrect signals that cause Langerhans cells to multiply excessively. One leading theory suggests that the disease begins with abnormal cells in the bone marrow, where blood cells are produced. These mutated cells then develop into monocytes (another type of white blood cell), which circulate through the bloodstream and eventually become the Langerhans cells that accumulate in various tissues throughout the body.[3]
The genetic mutations found in LCH cells are similar to those seen in certain cancers, which is why many experts now classify LCH as a neoplastic disorder (meaning it involves abnormal cell growth) or even as a form of blood cancer. However, it’s crucial to understand that these genetic abnormalities are present only in the diseased Langerhans cells themselves, not in the person’s other healthy cells. This means the mutations are not part of the person’s inherited genetic makeup and cannot be passed on to their children.[6]
Risk Factors for Developing LCH
While Langerhans cell histiocytosis appears to develop randomly in most cases, researchers have identified several factors that may increase a person’s risk of developing the condition. It’s important to understand that having one or more risk factors doesn’t mean someone will definitely develop LCH, and conversely, some people develop the disease without having any known risk factors at all.[5]
Family history plays a role in some cases. Children who have a parent with a history of cancer or who has LCH themselves appear to have a higher risk. Similarly, having a personal or family history of thyroid disease has been associated with increased risk. However, it bears repeating that LCH is not considered a hereditary condition in the traditional sense, as it doesn’t follow predictable inheritance patterns.[5]
Environmental exposures, particularly parental occupational exposures, have been linked to increased risk in children. Children whose parents were exposed to certain solvents in the workplace before the child’s birth may have higher risk. Similarly, parental exposure to metal, granite, or wood dust at work has been associated with the disease. These findings suggest that environmental factors might play a role in triggering the genetic changes that lead to LCH, though the exact mechanisms remain unclear.[5]
For adults, smoking stands out as a major risk factor, especially for pulmonary LCH (the form that affects the lungs). Most adults with lung LCH have a significant smoking history. In fact, lung involvement in adults is predominantly related to smoking, with most patients being current or past smokers. This form of the disease can sometimes improve if the person stops smoking.[4]
Other potential risk factors include having infections as a newborn, being of Hispanic ethnicity, and, interestingly, not being vaccinated as a child. The reasons behind these associations are not yet fully understood and continue to be subjects of research.[5]
Symptoms and How They Affect Patients
The symptoms of Langerhans cell histiocytosis vary tremendously from person to person because they depend entirely on which parts of the body are affected and how extensively the disease has spread. Some individuals experience only mild symptoms affecting a single area, while others face serious complications involving multiple organ systems. This wide variability makes LCH challenging to diagnose, as its symptoms can mimic many other conditions.[1]
Bone Involvement
Bones are the most commonly affected part of the body in LCH, with approximately 80 percent of patients developing lesions in one or more bones. When LCH affects bone, it can cause swelling or the appearance of a lump over the affected area. The skull is particularly vulnerable, as are the long bones of the arms and legs, the spine, hips, ribs, jaw, and the bones around the ears and eyes. The swelling may or may not be painful.[1][4]
Children with bone lesions may experience persistent bone pain that doesn’t go away with rest or simple pain relievers. They might develop fractures from minor injuries that normally wouldn’t cause a break, or even fractures that occur without any obvious cause. If the spine is involved, children may complain of neck pain or back pain and might have difficulty walking or develop a limp. When the skull is affected, persistent headaches can occur.[1]
Lesions in the bones around the ears can cause chronic ear infections, fluid draining from the ears, or the development of cysts in the ear. When bones around the eyes are affected, it can lead to bulging eyes, a condition called exophthalmos, as well as vision problems. Lesions in the jaw can cause teeth to become loose, fall out prematurely, or grow unevenly.[5]
Skin Manifestations
Skin symptoms are common in LCH and often provide the first visible clue that something is wrong. In infants, the disease frequently presents as a persistent scalp rash that parents and doctors initially mistake for cradle cap. This rash doesn’t respond to typical treatments and continues to worsen over time. The rash can also appear in body creases such as the groin, behind the ears, under the breasts (in older children or adults), in the armpits, and on the abdomen, back, or chest.[1][5]
In children and adults, skin involvement may manifest as flaky patches that resemble dandruff when on the scalp. Elsewhere on the body, the rash might appear as raised bumps or lesions that are red, brown, or purple in color. These skin changes can be intensely itchy or painful, causing significant discomfort. Some patients develop oozing blisters that can become infected if not properly cared for.[1]
LCH can also affect the nails, causing them to develop discolored grooves running across them. In more severe cases, the nails may harden abnormally or fall off completely. Ulcers may form behind the ears, in skin folds, or in the groin area, which can be painful and difficult to heal.[1]
Mouth and Dental Problems
When Langerhans cell histiocytosis affects the mouth and gums, it can create significant dental and oral health problems. Children with mouth involvement may develop swollen, tender gums that bleed easily. Their teeth may become loose even when it’s not the normal time for baby teeth to fall out, or permanent teeth may be lost. New teeth may grow in unevenly or fail to emerge properly.[1]
Painful sores or ulcers can develop on the lips, tongue, inside the cheeks, or on the roof of the mouth. These lesions can make eating, drinking, and speaking uncomfortable, potentially affecting a child’s nutrition and willingness to consume adequate food and fluids.[1]
Endocrine System Effects
The pituitary gland, a small but crucial gland at the base of the brain, is frequently affected by LCH. When the pituitary or the stalk connecting it to the brain develops lesions, it can disrupt the production of important hormones that control many body functions. One of the most common results is a condition called diabetes insipidus, which is completely different from the more familiar diabetes mellitus (sugar diabetes).[4]
Diabetes insipidus occurs when the pituitary can no longer produce adequate amounts of a hormone that helps the kidneys conserve water. Without this hormone, patients produce excessive amounts of very dilute urine and become extremely thirsty. Children with this condition may need to urinate much more frequently than normal and wake up multiple times during the night to drink and use the bathroom.[1]
Pituitary damage can also interfere with growth hormones, leading to delayed puberty in older children or failure to grow at a normal rate. Some individuals may experience fertility problems later in life. The pituitary influences thyroid function as well, and thyroid dysfunction can affect metabolism, body temperature, energy levels, skin and hair texture, and even behavior and mood.[4]
Liver and Spleen Involvement
When LCH affects the liver and spleen, it becomes a more serious situation. The abdomen may become swollen and distended due to enlargement of these organs or fluid accumulation. Children may develop jaundice, a yellowing of the skin and the whites of the eyes that occurs when the liver isn’t functioning properly. Diarrhea and vomiting may occur, and children may lose weight or fail to gain weight as expected for their age.[1]
Liver involvement is considered high-risk because the liver performs many essential functions, including filtering toxins from the blood, producing proteins necessary for blood clotting, and helping digest food. When LCH damages the liver significantly, it can be life-threatening and requires intensive treatment.[1]
Lung Problems
Lung involvement appears in about 15 to 20 percent of LCH cases overall but is much more common in adults, especially smokers. When LCH affects the lungs, it causes inflammation of the small airways (bronchioles) and blood vessels. Over time, this leads to stiffening of lung tissue and the formation of cysts (air-filled spaces) within the lungs. Patients develop breathing difficulties, chronic cough, and increased susceptibility to lung infections.[4]
The lung damage from LCH can be progressive and may lead to respiratory failure in severe cases. Adults with pulmonary LCH often notice shortness of breath with exertion that gradually worsens over time. Chest pain and breathing problems can significantly limit physical activity and quality of life.[4]
Blood and Bone Marrow Effects
When LCH cells invade the bone marrow, where new blood cells are made, they can crowd out the healthy cells that produce red blood cells, white blood cells, and platelets. This leads to a condition called pancytopenia, meaning low counts of all types of blood cells. The consequences can be severe.[4]
Low red blood cell counts cause anemia, making patients feel tired, weak, and short of breath even with minimal activity. Low white blood cell counts, particularly low numbers of infection-fighting cells called neutrophils, leave patients vulnerable to frequent and serious infections. Low platelet counts cause problems with blood clotting, leading to easy bruising, nosebleeds, and prolonged bleeding from minor cuts.[4]
Other Symptoms
LCH can cause various other symptoms depending on which organs are involved. Swollen lymph nodes, particularly in the neck, may be noticed. Some patients develop general symptoms of illness including fever that doesn’t have an obvious cause, profound fatigue and weakness, unintended weight loss, and poor appetite. Children may fail to eat normally or have difficulty feeding. In rare cases, about one in 50 people with LCH experience deterioration of brain function, called neurodegeneration, which can cause problems with coordination, balance, speech, thinking, and behavior.[4]
Prevention Strategies
Currently, there are no established methods to prevent Langerhans cell histiocytosis because the exact cause of the disease remains unclear. Since LCH appears to result from random genetic mutations that occur during a person’s lifetime rather than from inherited genetic factors, traditional prevention strategies don’t apply. The genetic changes that lead to LCH are not present at birth and cannot be predicted or prevented through genetic screening or counseling.[6]
However, understanding risk factors can help guide certain precautions. For adults, avoiding smoking or quitting if you currently smoke is the most important preventive measure, particularly for pulmonary LCH. Since there is a strong association between smoking and lung involvement in adult LCH, eliminating this risk factor makes sense not only for LCH prevention but for overall health.[4]
For expectant parents, awareness of occupational hazards may be relevant. Since parental exposure to certain chemicals and dusts has been associated with increased risk in children, pregnant women and their partners might consider minimizing exposure to solvents, metal dusts, granite dust, and wood dust when possible, especially in occupational settings. However, it’s important to note that these associations are statistical observations, and avoiding these exposures cannot guarantee prevention of the disease.[5]
Ensuring children receive their routine vaccinations may have some protective benefit, as not being vaccinated has been identified as a potential risk factor, though the mechanism for this association is not understood.[5]
Early detection rather than prevention may be the most practical approach for LCH. Parents and caregivers should be aware that persistent skin rashes that don’t respond to typical treatments, unexplained bone pain or swelling, chronic ear problems, dental issues without obvious causes, or unusual thirst and urination patterns in children warrant medical evaluation. While these symptoms have many possible causes, early diagnosis of LCH when it does occur can lead to better outcomes.[2]
How the Body Changes: Pathophysiology of LCH
Understanding what happens in the body during Langerhans cell histiocytosis requires looking at both the cellular level and how these cellular changes translate into the symptoms and complications patients experience. The disease fundamentally represents a disruption in normal immune system function and cell growth regulation.[3]
In healthy individuals, Langerhans cells are a type of dendritic cell that acts as part of the body’s immune defense system. These cells normally reside in the skin and other tissues, where they capture foreign substances like bacteria and viruses, process them, and present information about these threats to other immune cells. This process helps the body mount an appropriate immune response to fight infections.[1]
In LCH, genetic mutations disrupt the normal life cycle and behavior of these cells. The most common mutation affects the BRAF gene, which is part of a cellular signaling pathway that controls cell growth and division. When the BRAF gene develops the V600E mutation, it sends constant “grow and divide” signals to the cell, even when these signals aren’t appropriate. This leads to excessive proliferation of abnormal Langerhans cells.[4]
Current understanding suggests that the disease begins in the bone marrow, where blood cells originate. Mutations occur in early blood cell precursors, causing them to develop into abnormal cells with characteristics of Langerhans cells. These mutated cells then leave the bone marrow, circulate through the bloodstream, and migrate to various tissues throughout the body. When they reach tissues, they accumulate rather than performing their normal function and then dying off as healthy cells would.[3]
As these abnormal Langerhans cells build up in tissues, they trigger an inflammatory response. The body recognizes that something is wrong and sends other immune cells to the area, including normal white blood cells like eosinophils, T-cells, and macrophages. These various cell types, along with the abnormal Langerhans cells, form the characteristic lesions seen in LCH. Under a microscope, these lesions show clusters of Langerhans cells with their distinctive appearance (including special structures called Birbeck granules) surrounded by inflammatory cells.[3]
The lesions cause problems in several ways. First, they take up space, physically displacing normal tissue. When this occurs in bone, the lesions create holes or weakened areas that can lead to fractures. In organs like the liver or spleen, the accumulation of cells interferes with normal organ function. Second, the inflammatory process itself damages surrounding healthy tissue. Third, the lesions can compress nearby structures; for example, a lesion in the skull near the pituitary gland can compress the pituitary stalk, interrupting hormone signals.[1]
In the lungs, LCH causes inflammation of the small airways and blood vessels. Over time, this inflammatory process leads to destruction of normal lung architecture and the formation of cysts. The lung tissue becomes stiff and scarred, making it difficult for oxygen to pass from the air into the bloodstream. This process is particularly common in adult smokers, suggesting that smoking somehow triggers or exacerbates the disease process in lung tissue.[4]
When LCH affects the bone marrow, the abnormal Langerhans cells physically crowd out the spaces where normal blood cell production occurs. This leads to decreased production of red blood cells, white blood cells, and platelets, causing the various complications of pancytopenia. The severity of bone marrow involvement directly impacts prognosis, as adequate blood cell production is essential for life.[4]
Interestingly, not all cells in LCH lesions carry the genetic mutation. Studies have found that in some patients, the mutation can be detected in a small percentage of bone marrow cells, suggesting that the disease begins there even when obvious bone marrow involvement isn’t visible under the microscope. This finding supports the concept of LCH as a disorder of blood cell development rather than simply a disease of mature Langerhans cells in tissues.[3]
The inflammatory nature of LCH explains why some milder cases, particularly those affecting only the skin, can resolve spontaneously without treatment. In these situations, the body’s immune system may eventually gain control over the abnormal cell proliferation and clear the lesions. However, in more severe cases, especially those involving high-risk organs like the liver, spleen, or bone marrow, the disease process overwhelms the body’s ability to control it, and intensive treatment becomes necessary.[1]
Recent research has revealed that LCH represents a state of arrested cell maturation. The abnormal cells display characteristics of both immature and mature Langerhans cells, suggesting they have become stuck in an intermediate stage of development. This understanding has helped clarify why the disease shares features of both cancer (uncontrolled cell growth) and inflammatory conditions (tissue damage from immune responses).[3]
